We are live on ! Find out more
BIOA

BioAge Labs

144 hedge funds and large institutions have $599M invested in BioAge Labs in 2026 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 46 increasing their positions, 27 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 17

91% more capital invested

Capital invested by funds: $314M → $599M (+$285M)

70% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 27

26% more funds holding

Funds holding: 114144 (+30)

11.27% more ownership

Funds ownership: 66%77.26% (+11%)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

85% less call options, than puts

Call options by funds: $283K | Put options by funds: $1.95M

Holders
144
Holders Change
+30
Holders Change %
+26.32%
% of All Funds
1.77%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
49
Increased
46
Reduced
27
Closed
17
Calls
$283K
Puts
$1.95M
Net Calls
-$1.67M
Net Calls Change
-$2.38M
Name Holding Trade Value Shares
Change
Change in
Stake
Franklin Resources
26
Franklin Resources
California
$4.64M +$5.11M +265,373 New
Morgan Stanley
27
Morgan Stanley
New York
$4.55M -$997K -51,790 -17%
Charles Schwab
28
Charles Schwab
California
$4.32M +$528K +27,434 +12%
Northern Trust
29
Northern Trust
Illinois
$3.92M +$1.09M +56,677 +34%
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$3.75M +$4.13M +214,546 New
YIH
31
Y-Intercept (HK)
Hong Kong
$3.52M +$3.88M +201,337 New
VFT
32
Vanguard Fiduciary Trust
Pennsylvania
$3.43M +$3.77M +195,937 New
Marshall Wace
33
Marshall Wace
United Kingdom
$3.33M -$625K -32,476 -15%
Fidelity Investments
34
Fidelity Investments
Massachusetts
$3.33M +$1.4M +72,595 +62%
Invesco
35
Invesco
Georgia
$3.08M -$1.01M -52,563 -23%
Ensign Peak Advisors
36
Ensign Peak Advisors
Utah
$2.91M +$3.2M +166,224 New
JP Morgan Chase
37
JP Morgan Chase
New York
$2.75M +$2.92M +151,541 +688%
Goldman Sachs
38
Goldman Sachs
New York
$2.74M +$582K +30,200 +24%
Walleye Capital
39
Walleye Capital
New York
$2.65M +$325K +16,879 +13%
Renaissance Technologies
40
Renaissance Technologies
New York
$2.42M +$2.31M +120,188 +653%
ACM
41
ADAR1 Capital Management
Texas
$2.37M
ACM
42
Alessandra Capital Management
California
$1.89M -$536K -27,840 -21%
BGM
43
Burkehill Global Management
New York
$1.75M +$1.93M +100,000 New
Arrowstreet Capital
44
Arrowstreet Capital
Massachusetts
$1.54M +$1.69M +87,881 New
SFM
45
Sphera Funds Management
Israel
$1.51M -$3.01M -156,517 -64%
Bank of New York Mellon
46
Bank of New York Mellon
New York
$1.32M +$270K +14,008 +23%
Alyeska Investment Group
47
Alyeska Investment Group
Illinois
$1.31M +$1.44M +75,000 New
UBS Group
48
UBS Group
Switzerland
$1.22M +$763K +39,603 +133%
AQR Capital Management
49
AQR Capital Management
Connecticut
$1.21M +$335K +17,416 +34%
Wellington Management Group
50
Wellington Management Group
Massachusetts
$1.18M +$1.3M +67,681 New

BIOA Hedge Fund Activity: Q1 2026 in Review

144 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in BioAge Labs (BIOA) for Q1 2026, worth a combined $599M — up 91% from $314M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new BIOA positions and 17 closed out — a net gain of 32 holders — while 46 added to existing stakes and 27 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $32.4M. The largest seller was Adage Capital Partners, cutting an estimated $10.6M.

  • 144 institutional investors held BioAge Labs (BIOA) as of Q1 2026, up from 114 in Q4 2025.
  • Funds reported $599M of BioAge Labs stock for Q1 2026, up 91% quarter-over-quarter.
  • 49 funds opened new BioAge Labs positions in Q1 2026 and 17 closed out, a net change of +32 holders.
  • The largest BioAge Labs buyer in Q1 2026 was Janus Henderson Group, an estimated $32.4M added.
  • The largest BioAge Labs seller in Q1 2026 was Adage Capital Partners, an estimated $10.6M sold.

Based on aggregated 13F filings for Q1 2026.